Vytrus Biotech, S.A. (BME:VYT)
Spain · Delayed Price · Currency is EUR 5.70
0.00 (0.00%)
Last updated: Sep 10, 2025, 9:00 AM CET
Vytrus Biotech Revenue
In the year 2024, Vytrus Biotech had annual revenue of 6.09M EUR with 29.51% growth. Vytrus Biotech had revenue of 3.06M in the half year ending December 31, 2024, with 46.56% growth.
Revenue
6.09M
Revenue Growth
+29.51%
P/S Ratio
6.92
Revenue / Employee
164.60K
Employees
37
Market Cap
42.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.09M | 1.39M | 29.51% |
| Dec 31, 2023 | 4.70M | 219.70K | 4.90% |
| Dec 31, 2022 | 4.48M | 968.83K | 27.57% |
| Dec 31, 2021 | 3.51M | 1.28M | 57.47% |
| Dec 31, 2020 | 2.23M | 456.81K | 25.74% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.45B |
| Laboratorios Farmaceuticos Rovi | 749.00M |
| Almirall | 1.05B |
| Pharma Mar | 189.27M |
| Faes Farma | 543.77M |
| Clínica Baviera | 288.92M |
| Laboratorio Reig Jofre | 336.02M |
| Prim, S.A. | 233.36M |